Growth Metrics

Merck (MRK) Free Cash Flow Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 79.29%
Dec 31, 2025 -1.62%
Sep 30, 2025 39.80%
Jun 30, 2025 13.36%
Mar 31, 2025 44.04%
Dec 31, 2024 38.85%
Sep 30, 2024 21.10%
Jun 30, 2024 16.05%
Mar 31, 2024 24.64%
Dec 31, 2023 -17.91%
Sep 30, 2023 26.07%
Jun 30, 2023 -0.43%
Mar 31, 2023 -13.98%
Dec 31, 2022 -0.14%
Sep 30, 2022 36.72%
Jun 30, 2022 1.65%
Mar 31, 2022 136.04%
Dec 31, 2021 4.76%
Sep 30, 2021 7.19%
Jun 30, 2021 -3.90%
Mar 31, 2021 -39.15%
Dec 31, 2020 -12.01%
Sep 30, 2020 -15.63%
Jun 30, 2020 -11.05%
Mar 31, 2020 -16.37%
Dec 31, 2019 12.22%
Sep 30, 2019 -4.10%
Jun 30, 2019 2.72%
Mar 31, 2019 -19.23%
Dec 31, 2018 0.50%
Sep 30, 2018 -9.85%
Jun 30, 2018 7.77%
Mar 31, 2018 -18.74%
Dec 31, 2017 26.23%
Sep 30, 2017 -20.98%
Jun 30, 2017 3.27%
Mar 31, 2017 -15.20%
Dec 31, 2016 3.22%
Sep 30, 2016 -9.18%
Jun 30, 2016 -13.21%
Mar 31, 2016 6.28%
Dec 31, 2015 5.45%
Sep 30, 2015 5.85%
Jun 30, 2015 -4.08%
Mar 31, 2015 15.26%
Dec 31, 2014 -23.77%
Sep 30, 2014 53.58%
Jun 30, 2014 39.30%
Mar 31, 2014 35.19%